Atlas Trials

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

Clinical trial NCT02320604 · COMPLETED

Trial details

NCT number
NCT02320604
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Morbid Obesity
Start date
2018-03-22
Primary completion
2018-11-03
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.